Cargando…
Hypoxia-inducible tumour-specific promoters as a dual-targeting transcriptional regulation system for cancer gene therapy
Transcriptional targeting is the best approach for specific gene therapy. Hypoxia is a common feature of the tumour microenvironment. Therefore, targeting gene expression in hypoxic cells by placing transgene under the control of a hypoxia-responsive promoter can be a good strategy for cancer-specif...
Autores principales: | Javan, Bita, Shahbazi, Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533602/ https://www.ncbi.nlm.nih.gov/pubmed/28798809 http://dx.doi.org/10.3332/ecancer.2017.751 |
Ejemplares similares
-
Gene transcription and chromatin regulation in hypoxia
por: Batie, Michael, et al.
Publicado: (2020) -
Tumour-selective transcriptional targeting for breast cancer gene therapy
por: Hurst, HC
Publicado: (2000) -
Suggesting Tissue-Specific MSMB Gene Promoter as a Novel Approach for Prostate Targeted Gene Therapy
por: Darayee, Maryam, et al.
Publicado: (2022) -
Dual hypoxia-responsive supramolecular complex for cancer target therapy
por: Guo, Jian-Shuang, et al.
Publicado: (2023) -
Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts
por: Liu, J, et al.
Publicado: (2007)